NIWOT, Colo., Aug. 02, 2017 -- Crocs, Inc. (NASDAQ:CROX) today announced a product collaboration on a line of special-edition footwear styles for women and children, designed in partnership with Drew Barrymore.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/be183796-498a-4010-85c3-494a3e82452f
http://www.globenewswire.com/NewsRoom/AttachmentNg/217666e3-1f78-4b55-b083-c3450bf34df0
The Drew Barrymore ♥ Crocs line will launch globally in the spring of 2018, combining the comfort and bold colors consumers love about Crocs with touches of Barrymore’s personal design style – including exclusive graphics and embellishments.
Crocs began its partnership with the Golden Globe Award-winning actress, producer, director, cosmetics line creator, author and mother in late 2016 when she joined the brand’s “Come As You Are” campaign as one of four ambassadors touting the uniqueness of individuals and inspiring everyone to be comfortable in their own shoes. Barrymore will continue in that role throughout 2018, in addition to collaborating on her new line.
“Working with Crocs as an ambassador for ‘Come As You Are’ has reinforced what I have always loved about the brand – it’s optimism, versatility and comfort, with a little bit of quirkiness. In a word, it’s me,” Barrymore said. “Collaborating on the Drew Barrymore ♥ Crocs line was a natural next step in our partnership. I’m thrilled to share the love I put into designing these styles with the world.”
“Drew has been hands-on in making sure that our Drew Barrymore ♥ Crocs collaboration personifies her optimistic personality, upbeat attitude and unpretentious spirit, while continuing to celebrate one-of-a-kindness through the universal feeling of love,” said Michelle Poole, Crocs Sr. Vice President of Global Product and Marketing.
The Drew Barrymore ♥ Crocs product collaboration will feature two collections of special-edition shoes for women and children, featuring bright colors and new graphics that speak to Barrymore’s personality and design philosophy. The first collection will be available to consumers worldwide beginning in February of 2018, and will feature bold colors and custom-designed charms on special-edition Crocs Classic Clogs, Crocband Clogs and Sloane Slides. The second collection will launch in May of 2018, and will feature exclusive graphics on Crocs Classic Clogs, Crocband Clogs and Sloane Slides, as well as Isabella Sandals and Flips. Both collections will be available at select stores globally and on crocs.com.
About Crocs, Inc.
Crocs, Inc. (Nasdaq:CROX) is a world leader in innovative casual footwear for men, women and children. Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. All Crocs™ shoes feature Croslite™ material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, and lightweight qualities that Crocs fans know and love.
To learn more about Crocs, visit www.crocs.com.
Media Contact: Patrick Rich Crocs, Inc. 303-848-7000 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Italy Fines Apple €98.6 Million Over App Store Dominance
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



